Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-09-10 to 2024-10-01
Current total value of award: $24859.3
Description: 4565835334!XOLAIR 300 MG/2 ML AUTOINJECT 2ML